Purpose of the Test
- Assess the likelihood of Down syndrome (Trisomy 21).
- Detect risks of Edwards syndrome (Trisomy 18).
- Identify potential neural tube defects such as spina bifida.
A precise screening conducted during the second trimester to assess risks of Down syndrome and neural tube defects, providing essential insights for a healthy pregnancy and peace of mind.
Scientific name: Second Trimester Quadruple Screening Test (Quad Screen)
A blood test measuring AFP, hCG, Estriol, and Inhibin-A. It evaluates the risk of chromosomal abnormalities or neural tube defects between the 15th and 20th weeks of pregnancy.